Advances in the targeted therapy for chronic lymphocytic leukemia in the 54th ASH annual meeting
10.3760/cma.j.issn.1009-9921.2013.04.001
- VernacularTitle:慢性淋巴细胞白血病靶向治疗研究进展:第54届美国血液学会年会报道
- Author:
Yuhan CHEN
;
Kejie ZHANG
- Publication Type:Journal Article
- Keywords:
Leukemia,lymphocytic,chronic;
Targeted therapy;
ASH annual meeting
- From:
Journal of Leukemia & Lymphoma
2013;22(4):193-196,201
- CountryChina
- Language:Chinese
-
Abstract:
Recognition has been achieved in the molecular targeting of several key signaling transduction pathways governing cell survival and proliferation in chronic lymphocytic leukemia (CLL).A milestone in CLL treatment is reached.This review provides a brief summary of the 54th ASH annual meeting,focusing on recent advances in the preclinical and clinical investigation of promising target-directed therapeutic agents.
